Latest News for: cadenza

Edit

Launchpad Cadenza 完成 2.3 亿美元募资,将在数字资产等领域寻求合并交易

BitRSS 20 Dec 2025
ChainCatcher 消息,据 Globenewswire 报道,特殊目的收购公司 Launchpad Cadenza 宣布其发行的 A 类普通股和认股权证已在纳斯达克上市完成首次公开募股(IPO),总计募资 2.3 亿美元,相关资金现已存入信托,Cantor Fitzgerald 担任本次发行的唯一簿记管理人。该公司表示,后续将在区块链、金融科技和数字资产生态中寻求技术和软件基础设施公司进行合并、兼并、股份交换、资产收购、股份购买、重组或类似的业务合并。 ... .
Edit

Launchpad Cadenza Acquisition Corp I Announces Pricing of $200,000,000 Initial Public Offering

The Eagle-Tribune 18 Dec 2025
New York, NY, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Launchpad Cadenza Acquisition Corp I (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to ... .
Edit

Horses to follow this week away from the spotlight including Flowing Cadenza

Sporting Life 01 Dec 2025
David Massey continues his new column with a look at what's to come 'Away From the Spotlight' in the next seven days. By the time you’re reading this Monday morning I’ll be heading to that there London for the HWPA Awards Lunch ... .
Edit

Magic 8 Ball to perform at Freeport’s Cadenza

The Brunswick Times Record 12 Nov 2025
" data-image-caption=". Magic 8 Ball is Ted DeMille, Chris Dombrowski and Ben Hunsberger ... .
Edit

Cadenza Bio Announces Peer-Reviewed Study Showing Oral, Brain-Penetrant ERβ Ligands Drive Remyelination and Functional Recovery ...

Guymon Daily Herald 10 Oct 2025
Published in Scientific Reports, a Nature Portfolio journal, the study details dual acting small molecules that restore myelin, modulate inflammation, and improve visual pathway function in preclinical MS models ... .
Edit

Cadenza Bio Announces Peer-Reviewed Study Showing Oral, Brain-Penetrant ERβ Ligands Drive Remyelination and Functional Recovery in MS Models

PR Newswire 09 Oct 2025
9, 2025 /PRNewswire/ -- Cadenza Bio, Inc ... Seema Tiwari-Woodruff, Corresponding Author and Scientific Founder of Cadenza Bio ... Carol Curtis, Co-Founder and CEO of Cadenza Bio ... About Cadenza Bio, Inc. Cadenza Bio, Inc ... SOURCE Cadenza Bio, Inc.
  • 1
×